UPM/Sappi: Brussels Skeptical of New Remedies Amid Market Testing, Sources Say

The European Commission is skeptical that a new remedies package submitted by UPM and Sappi will be enough to assuage the regulator’s competition concerns over the proposed €1.42 billion ($1.56 billion) joint venture, as it market tests commitments with stakeholders, according to people familiar with the matter

Published on Nov 18, 2026

Already have an account? Log in.

This article is currently locked and only available to subscribers. Request a trial to receive unlimited access to all articles.

View Only Unlocked Articles

Copyright ©2026 The Capitol Forum. All Rights Reserved.